Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Focal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT06309966
What this trial is testing

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Not applicableLooking for participantsNCT06550726
What this trial is testing

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

Who this might be right for
Epilepsies, Partial
Chinese University of Hong Kong 66
Not applicableLooking for participantsNCT06241924
What this trial is testing

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

Who this might be right for
Parkinson DiseaseEpilepsy
University Hospital, Bordeaux 30
Testing effectiveness (Phase 2)Ended earlyNCT03370120
What this trial is testing

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Who this might be right for
Drug-Resistant EpilepsyFocal-Onset Seizures
UCB Biopharma SRL 406
Not applicableUnknownNCT05278221
What this trial is testing

TMS Combined With EEG/EMG as a Biomarker Predicting Antiepileptic Drug Response

Who this might be right for
Focal Epilepsy
Aristotle University Of Thessaloniki 42
Early research (Phase 1)Study completedNCT00918047
What this trial is testing

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Not applicableUnknownNCT06116279
What this trial is testing

First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study

Who this might be right for
EpilepsyFocal Cortical Dysplasia
Great Ormond Street Hospital for Children NHS Foundation Trust 6
Testing effectiveness (Phase 2)Ended earlyNCT05493293
What this trial is testing

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset SeizureFocal Onset Epilepsy
Neurocrine Biosciences 82
Large-scale testing (Phase 3)Study completedNCT00425282
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 566
Large-scale testing (Phase 3)Study completedNCT01262677
What this trial is testing

Once-A-Day Pregabalin For Partial Seizures

Who this might be right for
Partial SeizuresEpilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Not applicableLooking for participantsNCT06202976
What this trial is testing

Mapping Epileptic Networks Using Multimodal Imaging

Who this might be right for
Epilepsy in Children
Imagine Institute 75
Testing effectiveness (Phase 2)Study completedNCT00236860
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Testing effectiveness (Phase 2)Ended earlyNCT02625090
What this trial is testing

An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma SRL 42
Not applicableUnknownNCT02885207
What this trial is testing

Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed

Who this might be right for
Epilepsy
University Hospital, Strasbourg, France 200
Not applicableNot Yet RecruitingNCT07803692
What this trial is testing

High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years

Who this might be right for
Idiopathic Generalized Epilepsy
Oregon Health and Science University 10
Not applicableEnrolling By InvitationNCT07823465
What this trial is testing

RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World Study

Who this might be right for
Focal EpilepsyDrug-resistant Focal Epilepsy
NeuroPace 100
Next Page